Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-034656
Filing Date
2011-06-03
Accepted
2011-06-03 14:48:53
Documents
2
Period of Report
2011-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd314223.html 3  
1 FORM 3 rrd314223.xml 3 2144
2 POWER OF ATTORNEY rrd281837_318196.htm EX-24. 4566
  Complete submission text file 0001181431-11-034656.txt   8126
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3204 BEVERLY DRIVE DALLAS TX 75205
Business Address
MAULDIN JOHN F (Reporting) CIK: 0001522480 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31791 | Film No.: 11891780